Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Why Are Vallon Pharma Shares Surging Today

  • Vallon Pharmaceuticals Inc (NASDAQ:VLON) has engaged Ladenburg Thalmann & Co Inc to evaluate strategic alternatives for the Company to maximize shareholder value.
  • Vallon is focused on the development of new medications for CNS disorders.
  • Ladenburg will advise Vallon on the strategic review process, including exploring the potential for a possible merger, business combination, investment into the Company, purchase, license, or other acquisition of assets. 
  • Also Read: Why Vallon Pharma Shares Are Staring At 52-Week Low Today.
  • The Company continues to assess the best path forward for ADAIR, its novel abuse-deterrent formulation of amphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy, and ADMIR, its novel abuse-deterrent formulation of methylphenidate (Ritalin). 
  • The Company is also streamlining its operations to preserve its capital and cash resources.
  • Price Action: VLON shares are up 100.1% at $2.26 during the market session on the last check Friday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.